People taking Mounjaro at the 5 mg dose lose an average of 15% of their starting body weight over about 72 weeks, based on clinical trial data. For someone starting at 250 pounds, that translates to roughly 37 pounds. The results vary depending on whether you have type 2 diabetes and how long you stay on the medication, but 5 mg delivers meaningful weight loss even without moving to a higher dose.
Average Weight Loss on Mounjaro 5 mg
The clearest data comes from multiple large clinical trials. In studies of people with type 2 diabetes, Mounjaro 5 mg produced an average weight loss of 12 to 17 pounds over 40 to 52 weeks. The range across five major trials (known as the SURPASS series) looked like this:
- SURPASS-1 (40 weeks): 14 pounds lost
- SURPASS-2 (40 weeks): 17 pounds lost
- SURPASS-3 (52 weeks): 15 pounds lost
- SURPASS-4 (52 weeks): 14 pounds lost
- SURPASS-5 (40 weeks): 12 pounds lost
These numbers come from patients with type 2 diabetes, who typically lose less weight on these medications than people without diabetes. In the SURMOUNT-1 trial, which studied people with obesity but without diabetes, the 5 mg dose led to a 15% to 16% reduction in body weight over 72 weeks. That’s a substantially larger number because the trial ran longer and because the body tends to respond more aggressively to these drugs when insulin resistance isn’t as severe.
What the Timeline Looks Like
You won’t start on 5 mg right away. The standard protocol begins with a 2.5 mg dose for the first four weeks, which is purely an initiation dose to let your body adjust. After that initial month, your prescriber moves you up to 5 mg. Most people notice appetite changes within the first couple of weeks, but visible weight loss typically picks up once you reach the 5 mg level.
By month two on the medication (your first full month at 5 mg), clinical trial data suggests you can expect roughly 5% to 6% of your starting body weight gone. The rate of loss tends to be fastest in the first few months and then gradually slows, with most of the total weight loss achieved by month 9 to 12. Weight continues to drop modestly after that point, but the curve flattens.
How the 5 mg Dose Compares to Higher Doses
Mounjaro comes in doses of 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Weight loss is dose-dependent, meaning higher doses generally produce more loss. In the SURMOUNT-1 trial, the 10 mg dose led to about 21% body weight reduction and the 15 mg dose led to about 22% over 72 weeks, compared to roughly 16% at 5 mg.
That said, 5 mg is not a “low” dose in any practical sense. A 16% reduction in body weight is clinically significant, and many people find that 5 mg controls their appetite well enough that increasing isn’t necessary. The decision to stay at 5 mg or titrate higher depends on your response, your goals, and how well you tolerate the medication. Some prescribers keep patients at 5 mg for months before considering an increase, especially if weight is coming off steadily.
Why Mounjaro Works for Weight Loss
Mounjaro activates two gut hormone pathways simultaneously. One (GLP-1) slows stomach emptying, reduces appetite signals in the brain, and helps regulate blood sugar after meals. The other (GIP) works alongside GLP-1 to further improve insulin response and appears to enhance the weight-lowering effects beyond what either hormone could do alone. This dual action is what separates Mounjaro from older medications like semaglutide, which only targets the GLP-1 pathway.
At the 5 mg dose, both pathways are active enough to meaningfully reduce hunger and food intake. Most people describe feeling full faster during meals and losing interest in snacking between them. The effect isn’t subtle for most users.
Side Effects at the 5 mg Dose
Gastrointestinal symptoms are the most common side effects, and they tend to peak during the transition from one dose to the next. At 5 mg, clinical trials reported nausea in about 12% of patients and diarrhea in another 12%. Vomiting occurred in about 5%. These numbers are moderate, and for most people, the symptoms ease within a few weeks as the body adjusts.
The nausea tends to be worst in the first week or two after a dose increase and then fades. Eating smaller meals, avoiding high-fat foods, and staying hydrated all help. If side effects at 5 mg are manageable, that’s a good sign your body is tolerating the medication well, which matters if you eventually move to a higher dose.
Blood Sugar Benefits Beyond Weight Loss
If you have type 2 diabetes, the 5 mg dose also delivers significant improvements in blood sugar control. In the SURPASS-1 trial, up to 92% of participants across all Mounjaro doses reached an A1C below 7%, which is the standard target recommended by the American Diabetes Association. Up to 52% reached an A1C below 5.7%, which is the threshold for people without diabetes. These results were observed alongside the weight loss, not instead of it, meaning both benefits happen in parallel.
Even if you’re taking Mounjaro primarily for weight management, the metabolic improvements in blood sugar, insulin sensitivity, and related markers are real and contribute to long-term health outcomes that go beyond the number on the scale.
Individual Results Vary
Trial averages are useful benchmarks, but individual responses to Mounjaro 5 mg span a wide range. Some people lose more than 20% of their body weight at this dose. Others lose closer to 8% or 10%. Factors that influence your results include your starting weight, metabolic health, diet, physical activity, sleep quality, and genetics. People with more weight to lose and those without type 2 diabetes tend to see larger percentage drops.
If you’re losing weight steadily at 5 mg, there’s no clinical reason to rush to a higher dose. The medication continues working over many months, and patience during the first 6 to 9 months often pays off. Plateaus are common and don’t necessarily mean the dose has stopped working. They sometimes reflect the body adjusting to a new metabolic set point before further loss resumes.